Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glycyrrhizin (also known as glycyrrhizic acid or glycyrrhizinic acid) is a triterpene saponin and the chief sweet-tasting constituent of licorice root (*Glycyrrhiza glabra*). It is 30 to 50 times sweeter than sucrose and is used as a natural sweetener, emulsifier, and gel-forming agent in foodstuffs, cosmetics, and dietary supplements. Pharmacologically, it has been developed primarily in Japan and China as a hepatoprotective drug for chronic hepatitis. Glycyrrhizin exhibits anti-inflammatory, antiviral, anti-ulcer, antioxidant, antiallergic, antihyperglycemic, anti-lipidemic, immunomodulatory and potential antitumor activities. Its mechanisms include inhibition of viral replication (including hepatitis C virus), suppression of TNF-alpha and caspase 3 activity (anti-inflammatory), inhibition of NF-kB translocation into nuclei (anti-inflammatory), conjugation of free radicals (antioxidant), modulation of T-cell function via JNK/ERK/PI3K-AKT pathways (immunomodulation), reversible inhibition of the enzyme 11-beta-hydroxysteroid dehydrogenase leading to increased mineralocorticoid activity in the kidney. After oral ingestion it is hydrolyzed by intestinal bacteria to its aglycone enoxolone (18β-glycyrrhetinic acid). Glycyrrhizin has also been investigated for use against viral infections such as herpes simplex virus and SARS-associated coronavirus[2][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glycyrrhizin.